The Mainz-based pharmaceutical company Biontech is closing three German production sites in Marburg, Idar-Oberstein and Tübingen with a total of 1,800 employees because no buyers were found.
AI-generated summary
Biontech became world famous during the corona pandemic with its Covid-19 vaccine.
Three German production sites of the pharmaceutical company Biontech with a total of 1,800 employees will be closed. According to its own information, the Mainz-based company found no buyers for its plants in Marburg in Hesse, in Idar-Oberstein in Rhineland-Palatinate and in Tübingen in Baden-Württemberg.
Biontech became world famous during the corona pandemic with its Covid-19 vaccine.
More soon.

BioNTech is closing its locations in Marburg, Tübingen and Idar-Oberstein because no buyers were found. Around 1,800 employees are affected. In the future, the company will focus more on cancer research and respond to falling demand for vaccines.
The German labor market is showing the first signs of easing unemployment. Nevertheless, the IAB warns of a shrinking labor market due to demographic change. Immigrants are indispensable in many industries, especially in shortage occupations.
The insolvent foundry specialist Bohai Automotive is closing its main factory in Harzgerode by the end of January. Despite an intensive search for investors, no solution could be found, which resulted in the loss of around 550 jobs.

German companies suffer from inefficient leadership development. The 'fireplace career', a focus on administration instead of leadership and homogeneous selection processes by supervisory boards prevent necessary innovations and lead to frustration.
Covestro boss and VCI President Markus Steilemann speaks in an interview about the perception of Chancellor Friedrich Merz and the situation in German industry.

Biontech announces the closure of its three locations in Idar-Oberstein, Marburg and Tübingen by 2028, affecting around 1,800 employees. Failed sales attempts and a focus on cancer medicine are cited as reasons.